Funder: National Institutes of Health (NIH)
Due Dates: November 21, 2024 (final) | Rolling prior dates from Feb 21, 2022 to Nov 21, 2024
Funding Amounts: Up to $250,000 direct costs per year | Project period up to 2 years | Cost share 0.25:1 non-federal match required
Summary: Supports early-stage translational development for device prototype testing, diagnostic assay development, and research tool validation targeting heart, lung, blood, and sleep (HLBS) disorders.
Key Information: Clinical trials are not allowed; an Accelerator Partner and cost matching are required; projects must demonstrate preliminary data and regulatory/IP plans.